Monopar Therapeutics (MNPR) Change in Cash (2017 - 2020)

Monopar Therapeutics' Change in Cash history spans 4 years, with the latest figure at -$1.2 million for Q4 2020.

  • For Q4 2020, Change in Cash fell 114.28% year-over-year to -$1.2 million; the TTM value through Dec 2020 reached $3.5 million, down 44.26%, while the annual FY2024 figure was $38.6 million, 4289.72% up from the prior year.
  • Change in Cash for Q4 2020 was -$1.2 million at Monopar Therapeutics, down from $5.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $8.7 million in Q4 2019 and bottomed at -$1.2 million in Q4 2020.
  • The 4-year median for Change in Cash is -$628427.5 (2019), against an average of $866506.6.
  • The largest annual shift saw Change in Cash crashed 219.21% in 2018 before it surged 1301.86% in 2019.
  • A 4-year view of Change in Cash shows it stood at -$806020.0 in 2017, then rose by 9.99% to -$725493.0 in 2018, then soared by 1301.86% to $8.7 million in 2019, then plummeted by 114.28% to -$1.2 million in 2020.
  • Per Business Quant, the three most recent readings for MNPR's Change in Cash are -$1.2 million (Q4 2020), $5.4 million (Q3 2020), and -$46173.0 (Q2 2020).